vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and PURE CYCLE CORP (PCYO). Click either name above to swap in a different company.

PURE CYCLE CORP is the larger business by last-quarter revenue ($9.1M vs $7.8M, roughly 1.2× CRYO CELL INTERNATIONAL INC). PURE CYCLE CORP runs the higher net margin — 50.0% vs -48.7%, a 98.6% gap on every dollar of revenue. On growth, PURE CYCLE CORP posted the faster year-over-year revenue change (58.8% vs -2.3%). Over the past eight quarters, PURE CYCLE CORP's revenue compounded faster (69.0% CAGR vs -0.1%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Pure Cycles, is a bicycle company based in Los Angeles, California that was founded by Michael Fishman, Jordan Schau, Zachary Schau and Austin Stoffers in 2010, as Pure Fix Cycles.

CCEL vs PCYO — Head-to-Head

Bigger by revenue
PCYO
PCYO
1.2× larger
PCYO
$9.1M
$7.8M
CCEL
Growing faster (revenue YoY)
PCYO
PCYO
+61.1% gap
PCYO
58.8%
-2.3%
CCEL
Higher net margin
PCYO
PCYO
98.6% more per $
PCYO
50.0%
-48.7%
CCEL
Faster 2-yr revenue CAGR
PCYO
PCYO
Annualised
PCYO
69.0%
-0.1%
CCEL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CCEL
CCEL
PCYO
PCYO
Revenue
$7.8M
$9.1M
Net Profit
$-3.8M
$4.6M
Gross Margin
77.9%
68.4%
Operating Margin
-50.6%
48.0%
Net Margin
-48.7%
50.0%
Revenue YoY
-2.3%
58.8%
Net Profit YoY
-105.1%
16.0%
EPS (diluted)
$-0.46
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
PCYO
PCYO
Q4 25
$7.8M
$9.1M
Q3 25
$7.8M
$11.2M
Q2 25
$7.9M
$5.1M
Q1 25
$8.0M
$4.0M
Q4 24
$8.0M
$5.8M
Q3 24
$8.1M
$12.6M
Q2 24
$8.0M
$7.6M
Q1 24
$7.9M
$3.2M
Net Profit
CCEL
CCEL
PCYO
PCYO
Q4 25
$-3.8M
$4.6M
Q3 25
$749.4K
$6.1M
Q2 25
$355.8K
$2.3M
Q1 25
$282.9K
$809.0K
Q4 24
$-1.9M
$3.9M
Q3 24
$1.1M
$6.6M
Q2 24
$655.8K
$2.8M
Q1 24
$556.2K
$118.0K
Gross Margin
CCEL
CCEL
PCYO
PCYO
Q4 25
77.9%
68.4%
Q3 25
77.0%
67.7%
Q2 25
76.6%
63.4%
Q1 25
75.1%
38.2%
Q4 24
78.4%
63.8%
Q3 24
73.6%
77.8%
Q2 24
74.8%
64.0%
Q1 24
73.7%
55.6%
Operating Margin
CCEL
CCEL
PCYO
PCYO
Q4 25
-50.6%
48.0%
Q3 25
24.3%
53.1%
Q2 25
18.8%
26.0%
Q1 25
13.3%
-33.2%
Q4 24
-1.5%
29.9%
Q3 24
17.2%
62.0%
Q2 24
17.3%
40.3%
Q1 24
10.5%
-11.5%
Net Margin
CCEL
CCEL
PCYO
PCYO
Q4 25
-48.7%
50.0%
Q3 25
9.6%
54.5%
Q2 25
4.5%
43.9%
Q1 25
3.5%
20.3%
Q4 24
-23.2%
68.4%
Q3 24
13.0%
52.6%
Q2 24
8.2%
37.2%
Q1 24
7.1%
3.7%
EPS (diluted)
CCEL
CCEL
PCYO
PCYO
Q4 25
$-0.46
$0.19
Q3 25
$0.09
$0.26
Q2 25
$0.04
$0.09
Q1 25
$0.03
$0.03
Q4 24
$-0.23
$0.16
Q3 24
$0.13
$0.27
Q2 24
$0.08
$0.12
Q1 24
$0.07
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
PCYO
PCYO
Cash + ST InvestmentsLiquidity on hand
$3.3M
$17.1M
Total DebtLower is stronger
$8.4M
$8.0M
Stockholders' EquityBook value
$-18.6M
$147.5M
Total Assets
$61.7M
$168.1M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
PCYO
PCYO
Q4 25
$3.3M
$17.1M
Q3 25
$3.2M
$21.9M
Q2 25
$4.4M
$14.4M
Q1 25
$3.5M
$16.5M
Q4 24
$3.5M
$19.0M
Q3 24
$2.1M
$22.1M
Q2 24
$1.5M
$20.5M
Q1 24
$979.6K
$20.6M
Total Debt
CCEL
CCEL
PCYO
PCYO
Q4 25
$8.4M
$8.0M
Q3 25
$8.4M
$6.8M
Q2 25
$8.4M
$6.9M
Q1 25
$8.5M
$6.9M
Q4 24
$8.5M
$6.9M
Q3 24
$8.5M
$6.9M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
PCYO
PCYO
Q4 25
$-18.6M
$147.5M
Q3 25
$-14.8M
$142.7M
Q2 25
$-15.6M
$136.7M
Q1 25
$-14.7M
$134.4M
Q4 24
$-13.2M
$133.6M
Q3 24
$-9.6M
$129.7M
Q2 24
$-10.7M
$123.2M
Q1 24
$-10.3M
$120.4M
Total Assets
CCEL
CCEL
PCYO
PCYO
Q4 25
$61.7M
$168.1M
Q3 25
$63.2M
$162.3M
Q2 25
$64.4M
$151.7M
Q1 25
$64.4M
$149.7M
Q4 24
$64.7M
$149.7M
Q3 24
$62.9M
$147.4M
Q2 24
$62.6M
$140.4M
Q1 24
$61.7M
$135.2M
Debt / Equity
CCEL
CCEL
PCYO
PCYO
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
PCYO
PCYO
Operating Cash FlowLast quarter
$1.3M
$-979.0K
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
-0.21×
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
PCYO
PCYO
Q4 25
$1.3M
$-979.0K
Q3 25
$2.5M
$9.4M
Q2 25
$707.0K
$-503.0K
Q1 25
$954.1K
$-1.4M
Q4 24
$2.2M
$5.7M
Q3 24
$2.4M
$3.1M
Q2 24
$1.8M
$892.0K
Q1 24
$-356.9K
$-457.0K
Free Cash Flow
CCEL
CCEL
PCYO
PCYO
Q4 25
$1.2M
Q3 25
$2.5M
Q2 25
$644.6K
Q1 25
$892.0K
Q4 24
$2.1M
Q3 24
$2.3M
Q2 24
$21.5K
Q1 24
$-814.6K
FCF Margin
CCEL
CCEL
PCYO
PCYO
Q4 25
15.5%
Q3 25
31.9%
Q2 25
8.1%
Q1 25
11.2%
Q4 24
26.8%
Q3 24
27.9%
Q2 24
0.3%
Q1 24
-10.4%
Capex Intensity
CCEL
CCEL
PCYO
PCYO
Q4 25
0.9%
Q3 25
0.5%
Q2 25
0.8%
Q1 25
0.8%
Q4 24
0.1%
Q3 24
2.3%
Q2 24
21.8%
Q1 24
5.8%
Cash Conversion
CCEL
CCEL
PCYO
PCYO
Q4 25
-0.21×
Q3 25
3.38×
1.53×
Q2 25
1.99×
-0.22×
Q1 25
3.37×
-1.70×
Q4 24
1.44×
Q3 24
2.32×
0.47×
Q2 24
2.70×
0.32×
Q1 24
-0.64×
-3.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCEL
CCEL

Segment breakdown not available.

PCYO
PCYO

Construction$6.5M71%
Water And Wastewater Resource Development Segment$2.5M27%

Related Comparisons